Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study
Open Access
- 1 January 2016
- journal article
- research article
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2016, 1-10
- https://doi.org/10.1155/2016/9687052
Abstract
Background. Endoscopic retrograde cholangiopancreatography (ERCP) is an established treatment modality for bile duct disorders, but patients have a risk of post-ERCP pancreatitis (PEP) and biliary sepsis.Aim. To evaluate the effectiveness and safety of pancreatic stent for prophylaxis of PEP and biliary sepsis in high-risk patients with complicating common bile duct (CBD) disorders.Methods. Two hundred and six patients with complicating confirmed or suspected CBD disorders were randomly assigned to receive ERCP with pancreatic stenting (experimental group) or without stenting (control group). Primary outcome measure was frequency of PEP, and secondary outcome measures included operative time, blood loss, postoperative recovery times, and other ERCP-associated morbidities.Results. Baseline age, sex, CBD etiology, concomitant medical/surgical conditions, cannulation difficulty, and ERCP success were comparable between the two groups (all). Compared to the control group, the experimental group had a significantly lower frequency of PEP (7.7%versus17.7%,) and positive bile microbial culture (40.4%versus62.7%,). However, the two groups were similar in operative time, blood loss, postoperative recovery times, and other ERCP-associated morbidities (all).Conclusions. Pancreatic stenting can reduce the occurrence of PEP and biliary sepsis in high-risk patients with complicating CBD disorders but does not increase other ERCP-associated morbidities. This trial is registered with the Chinese Clinical Trial Registry (registration identifierChiCTR-OCH-14005134).
Keywords
Funding Information
- Guangdong Provincial Science and Technology (20120309)
This publication has 42 references indexed in Scilit:
- Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trialSurgical Endoscopy, 2012
- A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP PancreatitisThe New England Journal of Medicine, 2012
- Complications of ERCPGastrointestinal Endoscopy, 2012
- Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patientsGastrointestinal Endoscopy, 2012
- Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatographyWorld Journal of Gastroenterology, 2012
- Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic reviewGastrointestinal Endoscopy, 2011
- Risk of post-ERCP pancreatitis with placement of self-expandable metallic stentsGastrointestinal Endoscopy, 2010
- Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatographyWorld Journal of Gastroenterology, 2008
- Association of Periampullary Duodenal Diverticula with Bile Duct Stones and with Technical Success of Endoscopic Retrograde CholangiopancreatographyEndoscopy, 2004
- Post-ERCP Pancreatitis and Hyperamylasemia: Patient-Related and Operative Risk FactorsEndoscopy, 2002